Recently, Zhu et al. also demonstrated that Nrf-2 was significantly increased expressed in nucleus of CD133+ GSCs compared with CD133− glioma cells analysised by immunofluoresence staining [39]. Here, NFE2L2 is linked to central nervous system cancer.